title: Finasteride or dutasteride for the pharmacological treatment for male lower urinary tract symptoms due to benign prostatic hyperplasia?
authors.affiliation: Centro de Salud José María Álvarez, Don Benito, Badajoz, España. Electronic address: a.alcantara.montero@hotmail.com.
authors.forename: A
authors.initials: A
authors.lastname: Alcántara-Montero
authors.affiliation: Centro de Salud Llefiá, Badalona, Barcelona, España.
authors.forename: F J
authors.initials: FJ
authors.lastname: Brenes-Bermúdez
mesh_terms: D058891:5-alpha Reductase Inhibitors / Q000627:therapeutic use*; D000068538:Dutasteride / Q000627:therapeutic use*; D018120:Finasteride / Q000627:therapeutic use*; D006801:Humans; D059411:Lower Urinary Tract Symptoms / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D011470:Prostatic Hyperplasia / Q000150:complications / Q000188:drug therapy*
chemical_list: D058891:5-alpha Reductase Inhibitors; D018120:Finasteride; D000068538:Dutasteride